What is the relationship between Addison's disease and Type 1 Diabetes Mellitus (Type 1 DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Addison's disease is associated with Type 1 Diabetes Mellitus (Type 1 DM) as people with Type 1 DM are at increased risk for other autoimmune diseases, including primary adrenal insufficiency (Addison disease).

Relationship Between Addison's Disease and Type 1 DM

  • The association between Addison's disease and Type 1 DM is due to the autoimmune nature of both conditions, with Type 1 DM resulting from cell-mediated autoimmune destruction of the pancreatic b-cells 1.
  • People with Type 1 DM are prone to other autoimmune disorders, including Hashimoto thyroiditis, Graves disease, celiac disease, Addison disease, vitiligo, autoimmune hepatitis, myasthenia gravis, and pernicious anemia 1.
  • The high prevalence of autoimmune diseases in people with Type 1 DM highlights the importance of comprehensive medical evaluation and assessment of comorbidities, including screening for thyroid dysfunction and celiac disease 1.
  • While the exact mechanisms underlying the association between Addison's disease and Type 1 DM are not fully understood, it is clear that people with Type 1 DM are at increased risk for developing other autoimmune diseases, including primary adrenal insufficiency (Addison disease) 1.

From the Research

Relationship Between Addison's Disease and Type 1 Diabetes Mellitus

The relationship between Addison's disease and Type 1 Diabetes Mellitus (Type 1 DM) is characterized by their co-occurrence in autoimmune polyendocrine syndromes (APSs) 2. Key aspects of this relationship include:

  • Addison's disease can occur simultaneously with Type 1 DM in defined syndromes with distinct pathophysiology and characteristics, such as APS-1 and APS-2 2.
  • The combination of autoimmune adrenal insufficiency with autoimmune thyroid disease and/or Type 1 DM defines APS-2 2.
  • Continuous glucose monitoring (CGM) can suggest adrenal insufficiency in patients with Type 1 DM, particularly in cases of recurrent hypoglycemic episodes at dawn and reduced insulin requirement 3.
  • Addison's disease can be initially symptomless and characterized by slow progression up to acute adrenal crisis, which represents a potentially life-threatening condition 3, 4.

Clinical Implications

The co-existence of Addison's disease and Type 1 DM can lead to:

  • Challenges in acute clinical management, including the risk of hypoglycemia and diabetic ketoacidosis 4, 5.
  • Increased risk of premature death due to diabetic complications and cardiovascular disease 5.
  • Treatment challenges, including the need to balance and synchronize insulin and glucocorticoid replacement therapies 5.
  • Deterioration of glycemic control and increased rate of hypoglycemia 6.

Screening and Management

Screening for autoimmune diseases, such as Addison's disease, is important in patients with Type 1 DM, as it can help identify patients at higher risk of developing these conditions 6. Management strategies for patients with both Addison's disease and Type 1 DM include:

  • Insulin and glucocorticoid replacement therapies 5.
  • Periodic and careful evaluation of CGM data to suspect adrenal insufficiency 3.
  • Balancing and synchronizing insulin and glucocorticoid replacement therapies to minimize the risk of hypo- and hyperglycemia and diabetic ketoacidosis 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.